Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage.
about
Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated CardiotoxicityIntegrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 1Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicityExperimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculatureSulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cellsCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionResveratrol and cancer: focus on in vivo evidence.Cardiomyocyte death in doxorubicin-induced cardiotoxicityBoth aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes.Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animalsLycopene and chemotherapy toxicity.Age-related cardiovascular disease and the beneficial effects of calorie restriction.Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization.The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats.Effect of resveratrol on hematological and biochemical alterations in rats exposed to fluoride.Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats.Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats.Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation.Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats.Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity.Protective and therapeutic effects of resveratrol on acetic acid-induced gastric ulcer.Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.Resveratrol and adipose-derived mesenchymal stem cells are effective in the prevention and treatment of doxorubicin cardiotoxicity in rats.Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
P2860
Q26744634-C45A1304-888E-4834-8A0B-2C01AB0058A0Q26771931-A02FEF36-3481-485A-B247-F9C9B5F8D0DCQ26801409-82313B2A-8B04-419C-8F4D-6F7BB8EC9D09Q27016095-6B749BB6-6B32-4FDB-9E25-70F0833B8C4CQ28397899-C5215E09-26A6-467E-BD36-874D7F8CEC0DQ33574045-ECB0B4AD-1257-4CCF-9CFF-DD4AD6A83DF1Q33578943-7095639B-094A-4D40-B9CC-4F9E2EE96E32Q33604134-95EE241E-FCFF-45EE-9368-81DE1503AB24Q33976440-C6365194-33EF-474E-B6D2-59E8FA12820EQ34782924-FCC87D9C-107B-4E57-8AA3-81363EA55A6FQ35847671-C687185C-E2EB-4029-AF44-E03E68CB42C3Q36083507-0F105028-CAC2-480E-A91F-5757175D8995Q36562008-5FCDDBBB-D1A7-4E87-9539-1AFFEB1D3240Q36922988-E50261B8-BD97-42D6-9B43-D22C1B48CD4AQ37798223-828C4EE1-6462-4CD6-8D45-753CD1893D24Q37957749-6CBFC01C-71D3-4DA8-ACCA-F7035F29E903Q38654368-F1ECB255-7203-4028-822C-FB98F7E1DDBBQ38875916-5ECDF7DD-2CC4-4CBF-9AB0-8AEB29F3072BQ39426145-576004C9-FB6B-4E08-B66D-FEC6F621ABA6Q39581594-55669C56-729B-48A9-AC4B-860970D91DECQ41058653-5C97038D-A6E3-445D-B1C4-893D68D3C807Q41901068-9712B58A-61C4-4E52-9DDA-E1A748FCB3C1Q42153380-540B5544-6862-41A0-BE1E-F8E32DFFB304Q42705162-D38D079E-546E-4EF0-BF43-6BA9509D5F8DQ42708154-59489510-7FDF-435C-A466-10F4A11A7CD0Q42835418-25D04BE6-E44C-40CD-88D7-9F277CC739C3Q43234808-EA5F26CB-23CA-4712-935E-63DE53662D58Q43265295-49ADF7F3-432A-462E-91D7-99E8825B6037Q43285963-C12E2FFE-0DA8-4B5C-8D61-B1C0E1F6DD53Q45991064-5B2ED341-D7CD-43AA-85BD-11DD5567FE63Q47929053-450AC5E5-58EE-4200-8D6C-C98CD01F1692Q51276965-607DBCBA-62F3-4D1F-B687-AFCB43B0FE46Q54981841-421D77E7-177E-4331-8772-EF2BFCA28C36
P2860
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Resveratrol treatment protects ...... alleviating oxidative damage.
@en
Resveratrol treatment protects ...... alleviating oxidative damage.
@nl
type
label
Resveratrol treatment protects ...... alleviating oxidative damage.
@en
Resveratrol treatment protects ...... alleviating oxidative damage.
@nl
prefLabel
Resveratrol treatment protects ...... alleviating oxidative damage.
@en
Resveratrol treatment protects ...... alleviating oxidative damage.
@nl
P2093
P2860
P1476
Resveratrol treatment protects ...... alleviating oxidative damage.
@en
P2093
Ayliz Velioğlu-Oğünc
Aysen Yarat
Berrak C Yeğen
Elif Tatlidede
Göksel Sener
Ozer Sehirli
Selami Süleymanoğlu
Sule Cetinel
P2860
P304
P356
10.1080/10715760802673008
P577
2009-01-23T00:00:00Z